Today

Agents

Chat

Arena

Discover

More

App

LeonaBio spotlights lasofoxifene at DAVA Oncology breast cancer summit - LONA News | Rallies

LeonaBio spotlights lasofoxifene at DAVA Oncology breast cancer summit

LONA•2026-08-12

LeonaBio to present lasofoxifene data in Kona

LeonaBio will present lasofoxifene data at Dava Oncology’s 4th Summit on Breast Cancer in Kona, Hawaii, Aug. 18-22, 2026.

Jessica Tao will outline the Phase 3 ELAINE-3 trial of lasofoxifene with abemaciclib on Aug. 19, 2026.

David Portman will lead an industry lunch presentation on lasofoxifene development on Aug. 20, 2026.

Related News

Half-time in Europe: trying for gains

VGK•2026-08-12

Jensen Huang takes wheel of $500 bln AI bandwagon

NVDA•2026-08-12

Israel's BrainsWay Q2 revenue rises 35% to record high on higher shipments, utilization

BWAY•2026-08-12

LiqTech Q2 FY26 net loss widens 41.2% to $3.05 million; revenue falls 12% to $4.36 million

LIQT•2026-08-12

Netlist launches ITC patent infringement case against Micron over DDR5 memory products

NLST•2026-08-12